Skip to content

Hybrid Argon Plasma Coagulation (HybridAPC) versus resection in the surgical treatment of peritoneal endometriosis

Hybrid Argon Plasma Coagulation (HybridAPC) versus resection in the surgical treatment of peritoneal endometriosis - Hybrid-APC 001

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00011313
Enrollment
48
Registered
2017-04-26
Start date
2015-11-27
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N80

Interventions

Group 1: Peritoneal endometriotic lesions are treated with hybrid APC Group 2: Peritoneal endometriotic lesions are resected

Sponsors

Forschungsinstitut für FrauengesundheitDepartment für Frauengesundheit
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: all patients with peritoneal endometriotic lesions can be included, with no second laryoscopy (group A) and patients who need second laryoscopy to restore the TIE (group B).

Exclusion criteria

Exclusion criteria: - Age under 18 years - non-compliant patients - pregnant patients - patients with peritoneal endometriotic origin exclusively in the area of ??the ureter and close to the intestine - lack of patient consent

Design outcomes

Primary

MeasureTime frame
The primary target criterion is the histological eradication rate of the treated endometrium at the time of the second laparoscopy (approximately four to eight weeks after intervention)

Secondary

MeasureTime frame
- Investigation of the adhesion formation at the time of second laryoscopy (frequency of adhesion and adhesion quality) - Comparison of the duration of intervention per endometriosis lesions with different resection methods - size of the wound surface immediately after treatment in the first laparoscopy

Countries

Germany

Contacts

Public ContactBernhard Krämer

Department für Frauengesundheit

bernhard.kraemer@med.uni-tuebingen.de070712982211

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026